DeepMed Research

THE BRIGHAM AND WOMEN'S HOSPITAL, INC.

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Improving Glycemic Control on GMS: A Quality Improvement Study

Not Applicable

Completed

Conditions: Diabetes Mellitus

Interventions: Behavioral: Order Set, Education, Feedback

First Posted Date: 2006-01-04

Last Posted Date: 2019-08-13

Lead Sponsor: Brigham and Women's Hospital

Target Recruit Count: 179

Registration Number: NCT00271700

Locations: 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States

Physicians' Health Study II

Not Applicable

Completed

Conditions: Prostate Cancer
Eye Disease
Cognitive Decline
Cancer
Colorectal Cancer
Cardiovascular Disease

Interventions: Dietary Supplement: Vitamin E
Dietary Supplement: Vitamin C
Dietary Supplement: Multivitamin
Dietary Supplement: Beta-carotene

First Posted Date: 2005-12-28

Last Posted Date: 2018-02-28

Lead Sponsor: Brigham and Women's Hospital

Target Recruit Count: 14641

Registration Number: NCT00270647

Stress, Environment, and Genetics in Urban Children With Asthma

Completed

Conditions: Asthma
Lung Diseases

First Posted Date: 2005-12-23

Last Posted Date: 2016-02-03

Lead Sponsor: Brigham and Women's Hospital

Target Recruit Count: 959

Registration Number: NCT00269256

Locations: 🇺🇸
Brigham & Women's Hospital, Boston, Massachusetts, United States

Treatment of Refractory Status Epilepticus

Phase 3

Terminated

Conditions: Status Epilepticus

Interventions: Drug: thiopental/pentobarbital
Drug: propofol

First Posted Date: 2005-12-15

Last Posted Date: 2013-04-09

Lead Sponsor: Brigham and Women's Hospital

Target Recruit Count: 23

Registration Number: NCT00265616

Locations: 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States
🇨🇭
Inselspital, Bern, BE, Switzerland
🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

and more 2 locations

MDMA-assisted Therapy in People With Anxiety Related to Advanced Stage Cancer

Phase 2

Terminated

Conditions: Cancer
Anxiety Disorder

Interventions: Drug: Stage 1 Active Methylenedioxymethamphetamine
Drug: Stage 1 Low dose Methylenedioxymethamphetamine
Drug: Stage 2 Active Methylenedioxymethamphetamine
Behavioral: Psychotherapy

First Posted Date: 2005-11-11

Last Posted Date: 2017-11-14

Lead Sponsor: Brigham and Women's Hospital

Target Recruit Count: 2

Registration Number: NCT00252174

Locations: 🇺🇸
McLean Hospital, Belmont, Massachusetts, United States

Comprehensive Police Fatigue Management Program

Not Applicable

Completed

Conditions: Sleep Disorders
Sleep Apnea, Obstructive
Restless Legs Syndrome
Sleep Disorders, Circadian Rhythm
Sleep Initiation and Maintenance Disorders

Interventions: Behavioral: Sleep Hygiene Education
Other: Expert-Led Sleep Disorders Screening and Treatment
Other: Online Sleep Disorders Screening

First Posted Date: 2005-10-30

Last Posted Date: 2013-08-15

Lead Sponsor: Brigham and Women's Hospital

Target Recruit Count: 683

Registration Number: NCT00246051

Locations: 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States

Improving Safety and Quality With Outpatient Order Entry

Not Applicable

Conditions: Ambulatory Care Information Systems
Clinical Decision Support Systems

Interventions: Other: Integration of advanced clinical decision support with ambulatory computerized physician order entry

First Posted Date: 2005-10-24

Last Posted Date: 2013-02-18

Lead Sponsor: Brigham and Women's Hospital

Target Recruit Count: 800

Registration Number: NCT00243334

Locations: 🇺🇸
Partners HealthCare System, Inc., Boston, Massachusetts, United States

Using Barcode Technology to Improve Medication Safety

Not Applicable

Completed

Conditions: Impact of Barcode Technology on Medication Errors

First Posted Date: 2005-10-24

Last Posted Date: 2012-01-19

Lead Sponsor: Brigham and Women's Hospital

Target Recruit Count: 6700

Registration Number: NCT00243373

Locations: 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States

Melatonin Supplements for Improving Sleep in Individuals With Hypertension

Phase 2

Completed

Conditions: Sleep Disorders
Hypertension

Interventions: Drug: Placebo
Drug: Melatonin

First Posted Date: 2005-10-13

Last Posted Date: 2017-11-14

Lead Sponsor: Brigham and Women's Hospital

Target Recruit Count: 16

Registration Number: NCT00238108

Locations: 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States

A Randomized, Double-Blind, Placebo-Controlled Trial of Simvastatin on Subarachnoid Hemorrhage-Induced Vasospasm

Phase 1

Completed

Conditions: Delayed Vasospasm
Subarachnoid Hemorrhage

First Posted Date: 2005-10-12

Last Posted Date: 2008-10-16

Lead Sponsor: Brigham and Women's Hospital

Target Recruit Count: 104

Registration Number: NCT00235963

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy